Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Stock Holdings Boosted by Humankind Investments LLC

Humankind Investments LLC grew its position in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 34.6% during the 4th quarter, Holdings Channel reports. The firm owned 48,650 shares of the pharmacy operator’s stock after purchasing an additional 12,493 shares during the period. Humankind Investments LLC’s holdings in Walgreens Boots Alliance were worth $454,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors also recently modified their holdings of the company. First Financial Corp IN grew its holdings in Walgreens Boots Alliance by 49.2% during the fourth quarter. First Financial Corp IN now owns 2,685 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 885 shares during the period. Golden State Wealth Management LLC bought a new position in shares of Walgreens Boots Alliance during the 4th quarter valued at about $26,000. Riverview Trust Co raised its holdings in shares of Walgreens Boots Alliance by 123.8% in the 4th quarter. Riverview Trust Co now owns 2,874 shares of the pharmacy operator’s stock worth $27,000 after purchasing an additional 1,590 shares in the last quarter. Colonial Trust Co SC grew its position in Walgreens Boots Alliance by 79.5% in the fourth quarter. Colonial Trust Co SC now owns 2,928 shares of the pharmacy operator’s stock worth $27,000 after buying an additional 1,297 shares during the last quarter. Finally, Venturi Wealth Management LLC bought a new position in shares of Walgreens Boots Alliance in the fourth quarter valued at $28,000. Institutional investors own 58.59% of the company’s stock.

Walgreens Boots Alliance Trading Up 0.7 %

Shares of NASDAQ WBA opened at $11.24 on Friday. The business has a 50 day simple moving average of $11.00 and a 200 day simple moving average of $10.29. Walgreens Boots Alliance, Inc. has a 52 week low of $8.08 and a 52 week high of $18.83. The stock has a market cap of $9.72 billion, a price-to-earnings ratio of -1.10, a PEG ratio of 1.31 and a beta of 0.77. The company has a debt-to-equity ratio of 0.68, a quick ratio of 0.30 and a current ratio of 0.64.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Tuesday, April 8th. The pharmacy operator reported $0.63 earnings per share for the quarter, beating analysts’ consensus estimates of $0.53 by $0.10. The business had revenue of $38.59 billion for the quarter, compared to the consensus estimate of $37.90 billion. Walgreens Boots Alliance had a negative net margin of 5.87% and a positive return on equity of 17.61%. Walgreens Boots Alliance’s revenue for the quarter was up 4.1% on a year-over-year basis. During the same quarter last year, the firm earned $1.20 EPS. On average, research analysts predict that Walgreens Boots Alliance, Inc. will post 1.6 earnings per share for the current fiscal year.

Insider Transactions at Walgreens Boots Alliance

In other news, Chairman Stefano Pessina bought 832,258 shares of the stock in a transaction that occurred on Sunday, April 27th. The shares were acquired at an average cost of $11.01 per share, for a total transaction of $9,163,160.58. Following the purchase, the chairman now owns 145,621,079 shares of the company’s stock, valued at $1,603,288,079.79. This represents a 0.57 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 17.50% of the stock is currently owned by corporate insiders.

Analyst Upgrades and Downgrades

Several equities research analysts have recently commented on WBA shares. Royal Bank of Canada upped their target price on Walgreens Boots Alliance from $9.00 to $12.00 and gave the company a “sector perform” rating in a report on Wednesday, January 15th. StockNews.com initiated coverage on shares of Walgreens Boots Alliance in a research note on Monday, May 5th. They set a “hold” rating for the company. Bank of America lifted their target price on shares of Walgreens Boots Alliance from $7.50 to $8.50 and gave the stock an “underperform” rating in a research report on Monday, January 13th. Deutsche Bank Aktiengesellschaft downgraded shares of Walgreens Boots Alliance from a “hold” rating to a “sell” rating and reduced their price target for the company from $11.00 to $9.00 in a research report on Friday, February 28th. Finally, Truist Financial lowered their price objective on shares of Walgreens Boots Alliance from $13.00 to $12.00 and set a “hold” rating on the stock in a research report on Friday, January 31st. Four investment analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and an average price target of $10.59.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.